Clinical Trials
4
Active:0
Completed:2
Trial Phases
2 Phases
Phase 2:1
Not Applicable:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Not Applicable
2 (66.7%)Phase 2
1 (33.3%)Proning Early in Awake COVID-19 Hypoxic Respiratory Failure (PREACHR) Study
Not Applicable
Completed
- Conditions
- Respiratory FailureCovid19
- First Posted Date
- 2021-11-23
- Last Posted Date
- 2021-11-23
- Lead Sponsor
- New York Hospital Queens
- Target Recruit Count
- 219
- Registration Number
- NCT05130541
- Locations
- 🇺🇸
New York Presbyterian Queens, Flushing, New York, United States
An Open-Label Study of Vascazen in Cardiac Rehab Patients With Deficient Blood Omega-3 Fatty Acid Levels
Phase 2
- Conditions
- Dyslipidemia
- First Posted Date
- 2014-02-03
- Last Posted Date
- 2014-02-03
- Lead Sponsor
- New York Hospital Queens
- Target Recruit Count
- 100
- Registration Number
- NCT02052986
- Locations
- 🇺🇸
The NYHQ Cardiac Health Center, Fresh Meadows, New York, United States
Confusion in the Elderly After Colon Surgery
- Conditions
- ConfusionInflammationSurgeryAcute Phase ReactionDelirium
- First Posted Date
- 2012-06-19
- Last Posted Date
- 2012-06-19
- Lead Sponsor
- New York Hospital Queens
- Target Recruit Count
- 52
- Registration Number
- NCT01623297
- Locations
- 🇺🇸
New York Hospital Queens, Flushing, New York, United States
Prophylactic Continuous Positive Airway Pressure (CPAP) in Delivery Room, in the Prevention of Transient Tachypnea of Newborn (TTN): A Randomized Controlled Trial
Not Applicable
Completed
- Conditions
- Transient Tachypnea
- First Posted Date
- 2010-03-09
- Last Posted Date
- 2015-10-06
- Lead Sponsor
- New York Hospital Queens
- Target Recruit Count
- 138
- Registration Number
- NCT01082900
- Locations
- 🇺🇸
New York Hospital Queens, Flushing, New York, United States
News
No news found